TGFB1 and nephrocalcinosis: We hypothesized that anti-TGFβ IgG may not only inhibit interstitial fibrosis but also influence the crystallization of CaOx inside the kidney, which both should synergize to prevent nephrocalcinosis-related GFR decline, i.e., CKD progression.